相似文献
1
Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseases.
Trends Pharmacol Sci. 2010 May;31(5):199-205. doi: 10.1016/j.tips.2010.01.003. Epub 2010 Feb 19.
2
Theranostic nanoparticles for cancer and cardiovascular applications.
Pharm Res. 2014 Jun;31(6):1390-406. doi: 10.1007/s11095-013-1277-z. Epub 2014 Mar 5.
3
Imaging and nanomedicine in inflammatory atherosclerosis.
Sci Transl Med. 2014 Jun 4;6(239):239sr1. doi: 10.1126/scitranslmed.3005101.
4
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
J Magn Reson Imaging. 2007 Apr;25(4):667-80. doi: 10.1002/jmri.20866.
5
Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
Curr Probl Cardiol. 2023 May;48(5):101599. doi: 10.1016/j.cpcardiol.2023.101599. Epub 2023 Jan 18.
6
Nanomedicine strategies for molecular targets with MRI and optical imaging.
Future Med Chem. 2010 Mar;2(3):471-90. doi: 10.4155/fmc.10.5.
7
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors.
Int J Nanomedicine. 2014 Jan 22;9:589-613. doi: 10.2147/IJN.S50941. eCollection 2014.
8
Nanomedicine in the Diagnosis and Treatment of Atherosclerosis-A Systematic Review.
Cardiovasc Hematol Disord Drug Targets. 2017;17(2):119-131. doi: 10.2174/1871529X17666170918142653.
9
Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and Related Ischemic Diseases.
Adv Healthc Mater. 2020 Aug;9(16):e2000336. doi: 10.1002/adhm.202000336. Epub 2020 Jun 29.
10
Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
Int J Mol Sci. 2022 Jan 26;23(3):1404. doi: 10.3390/ijms23031404.
引用本文的文献
1
Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy.
Mater Today Bio. 2025 Aug 23;34:102238. doi: 10.1016/j.mtbio.2025.102238. eCollection 2025 Oct.
2
Nanomedicine and clinical diagnostics part I: applications in conventional imaging (MRI, X-ray/CT, and ultrasound).
Nanomedicine (Lond). 2025 Jan;20(2):167-182. doi: 10.1080/17435889.2024.2439776. Epub 2024 Dec 11.
3
Physiological principles underlying the kidney targeting of renal nanomedicines.
Nat Rev Nephrol. 2024 Jun;20(6):354-370. doi: 10.1038/s41581-024-00819-z. Epub 2024 Feb 26.
4
Advances in Natural and Bio-Inspired Nanoparticles for the Treatment of Cardiovascular Diseases.
Nanomaterials (Basel). 2023 Nov 24;13(23):3015. doi: 10.3390/nano13233015.
5
Biomimetic cell membrane-coated poly(lactic--glycolic acid) nanoparticles for biomedical applications.
Bioeng Transl Med. 2022 Nov 2;8(2):e10441. doi: 10.1002/btm2.10441. eCollection 2023 Mar.
6
Effect of Thermal Radiation on Three-Dimensional Magnetized Rotating Flow of a Hybrid Nanofluid.
Nanomaterials (Basel). 2022 May 5;12(9):1566. doi: 10.3390/nano12091566.
7
Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.
Pharmaceuticals (Basel). 2022 Apr 1;15(4):441. doi: 10.3390/ph15040441.
8
Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases.
Molecules. 2021 Dec 3;26(23):7340. doi: 10.3390/molecules26237340.
9
Lanthanide complexes with polyaminopolycarboxylates as prospective NMR/MRI diagnostic probes: peculiarities of molecular structure, dynamics and paramagnetic properties.
J Incl Phenom Macrocycl Chem. 2022;102(1-2):1-33. doi: 10.1007/s10847-021-01112-3. Epub 2021 Nov 11.
10
The Flow of Blood-Based Hybrid Nanofluids with Couple Stresses by the Convergent and Divergent Channel for the Applications of Drug Delivery.
Molecules. 2021 Oct 20;26(21):6330. doi: 10.3390/molecules26216330.
本文引用的文献
1
The rational design of nitric oxide selectivity in single-walled carbon nanotube near-infrared fluorescence sensors for biological detection.
Nat Chem. 2009 Sep;1(6):473-81. doi: 10.1038/nchem.332. Epub 2009 Aug 24.
2
Mitotic trafficking of silicon microparticles.
Nanoscale. 2009 Nov;1(2):250-9. doi: 10.1039/b9nr00138g. Epub 2009 Oct 5.
3
Visualizing sodium dynamics in isolated cardiomyocytes using fluorescent nanosensors.
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16145-50. doi: 10.1073/pnas.0905909106. Epub 2009 Sep 3.
4
Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle.
J Am Chem Soc. 2009 Oct 28;131(42):15522-7. doi: 10.1021/ja906797z.
5
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
Am Heart J. 2009 Sep;158(3):386-91. doi: 10.1016/j.ahj.2009.06.011. Epub 2009 Jul 15.
6
Sensitive and efficient detection of thrombus with fibrin-specific manganese nanocolloids.
Chem Commun (Camb). 2009 Jun 14(22):3234-6. doi: 10.1039/b902875g. Epub 2009 Apr 22.
7
Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study.
Clin Chem. 2009 Aug;55(8):1530-8. doi: 10.1373/clinchem.2008.117713. Epub 2009 Jun 25.
8
Molecular photoacoustic tomography with colloidal nanobeacons.
Angew Chem Int Ed Engl. 2009;48(23):4170-3. doi: 10.1002/anie.200805947.
9
Optical and multimodality molecular imaging: insights into atherosclerosis.
Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1017-24. doi: 10.1161/ATVBAHA.108.165530. Epub 2009 Apr 9.
10
Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
JACC Cardiovasc Imaging. 2008 Sep;1(5):624-34. doi: 10.1016/j.jcmg.2008.06.003.
Zotero 插件